GenomeMe

Immunohistochemistry Antibodies

GenomeMe Lab Inc. is a Vancouver-based biotech company specializing in mouse and rabbit IHC (immunohistochemistry) monoclonal antibodies for clinical diagnostic use. Since GenomeMe inception in 2017, they goal has been to develop each of the 260+ clinical IHC antibodies in-house.
Because they develop and manufacture all of their antibodies in-house, they are able to offer their distributors, and valuable end user customers the best value and quality. GenomeMe Lab Inc. is rising to be a dominant player in diagnostic IHC applications, an increasingly essential part of future precision medicine technologies.